Posted by Michael Wonder on 24 May 2018
Cancer drug spending doubles in 5 years
25 May 2018 - Every new cancer drug cost US$100,000 or more in 2017.
Spending on cancer drugs has doubled over the past five years, and little wonder: Every new cancer drug brought to market last year cost $100,000 or more, according to a new report.
Those drug costs are expected to double again by 2022, the report finds. That compares to the average $79,000 cost of new cancer drugs that hit the market in 2013.
